Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

6.2K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Speciation Studies of Monosubstituted Pt, Mo, and W Decavanadates in Culture Media and In Vitro Activity Against Trypanosoma cruzi.

ChemMedChem·2026
Same author

Harmonized <sup>1</sup>H NMR Workflow Enables Quantitative Betaine Determination from Nontargeted Metabolite Profiling Using Internal and External Standards<sup>‡‡‡‡‡</sup>.

Analytical chemistry·2026
Same author

Acute respiratory distress syndrome in patients with obesity.

Intensive care medicine·2026
Same author

Quality and Readability of Large Language Models' Responses to Oral Lichen Planus Patients' FAQs.

Oral diseases·2026
Same author

Gaps or paradoxes in clinical responses in obese patients.

Intensive care medicine·2026
Same author

Mechanical ventilation for ICU patient with obesity: current best practices and future directions.

Intensive care medicine·2026

相关实验视频

Updated: May 5, 2026

SorLA and CLC:CLF-1-dependent Downregulation of CNTFR&#945; as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

7.2K

3-基-3-甲基氨酸共酶A降解酶抑制剂降低了激活的人类T淋巴细胞中的Fas联体表达和细胞毒性.

Luis Miguel Blanco-Colio1, Begoña Muñoz-García, Jose Luis Martín-Ventura

  • 1Vascular Research Laboratory, Fundación Jiménez Díaz, Universidad Autónoma de Madrid, Madrid, Spain.

Circulation
|September 4, 2003
PubMed
概括

像阿托瓦斯塔丁这样的他类药物降低了T细胞FasL表达和细胞毒性,可能是通过抑制RhoA前. 这种机制可以解释他类药物如何降低动脉样硬化斑块细胞含量.

更多相关视频

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K
Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

4.2K

相关实验视频

Last Updated: May 5, 2026

SorLA and CLC:CLF-1-dependent Downregulation of CNTFR&#945; as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
10:16

SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry

Published on: January 6, 2017

7.2K
Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

8.9K
Assessment of Human Natural Killer Cell Events Driven by Fc&#947;RIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on: May 22, 2020

4.2K

科学领域:

  • 心血管研究研究心血管研究
  • 免疫学 免疫学 免疫学
  • 分子生物学分子生物学

背景情况:

  • HMG-CoA减少酶抑制剂 (他类药物) 通过不完全理解的机制减少心血管死亡率.
  • 动脉样硬化斑块中存在T细胞和亡细胞,细胞性降低表明斑块稳定性.
  • 法斯-法斯连接体 (FasL) 系统是T细胞介导的亡的关键途径.

研究的目的:

  • 调查HMG-CoA减少酶抑制剂是否调节人类T细胞中的FasL表达和细胞毒性.
  • 阐明了FasL表达通过他类药物调节的分子机制.

主要方法:

  • 人类T细胞 (Jurkat细胞) 被激活并用阿托瓦斯塔丁或西姆瓦斯塔丁治疗.
  • 在FasL表达中蛋白质前化和Rho GTPases的作用被评估使用了mevalonate,geranylgeranylpyrophosphate,farnesylpyrophosphate和C3外毒素.
  • 使用构成性活跃和主导负构造来操纵RhoA信号.
  • 使用对FasL敏感的细胞测量了细胞毒性活性.
  • 在外周血液单核细胞和人脉动脉动脉样硬化斑块中,FasL表达也被分析.

主要成果:

  • 阿托瓦斯塔丁和西姆瓦斯塔丁可以防止激活的T细胞上FasL表达的增加.
  • 蛋白质基兰化,特别是基兰基兰化和RhoA信号传递与T细胞FasL表达有关.
  • 阿托瓦斯塔丁降低了激活的T细胞的细胞毒性活性.
  • 阿托瓦斯塔丁降低了外周血液单核细胞和动脉样硬化斑块中的FasL表达.

结论:

  • 阿托瓦斯塔丁调节T细胞中的FasL表达,可能是通过抑制RhoA前.
  • 这些发现表明,阿托瓦斯塔丁通过一种新的机制影响T细胞细胞毒性和动脉样硬化斑块内的细胞含量.